Complementary Place of Cannabis in the Integrative Treatment Plan
Ilya Reznik / International Association for Cannabis as Medicine (IACM) – Izrael
Sunday, 4. 11. 2018, 14:15 – 15:00
Cannafest Conference 2018
“Marijuana is unique among illegal drugs in its political symbolism, its safety, and its wide use”.
Complementary and alternative medicine (CAM) therapies are nonconventional therapies used in addition to or instead of physician-recommended therapies. CAM use is prevalent in 45%–80% of patients with chronic illnesses, particularly among women, people with higher education levels, and those report poorer health. There is increasing global awareness and interest in the use of cannabis for therapeutic purposes, especially in such cases. To date, more than 140 different cannabinoids have been identified in cannabis. Other identified compounds include terpenoids, ﬂavonoids, nitrogenous compounds, and more common plant molecules. Therefore, due to such complex nature, cannabis possess wide-range non-specific health-related effects. Since conventional approved treatments are imperfect, and patients and families are often desperate to find alternatives, using of cannabis (in various forms and products), could be a valuable addition, leading to improvement of patients’ well-being and quality of their lives. Such an integrative approach makes cannabis a natural complementary ally in helping patients, especially with chronic disorders. Indeed, there is an obvious need for continued research both in regard to maximizing cannabis’s complex therapeutic effects and minimizing its adverse effects, and for proper education and training of health care professionals working in this highly developing and intriguing area.
Dr. Ilya Reznik is a board-certified specialist in Adult Forensic & Clinical NeuroPsychiatry at MaReNa Diagnostic and Consulting Center, Israel. Dr. Ilya Reznik has superior educational and professional record and documented contributions to the field of neuropsychiatric research, such as publications and other innovative activities. Dr. Reznik has published many original papers (including controlled trials), reviews and case reports in leading peer-reviewed journals in the field of clinical psychiatry and neuropsychopharmacology. His current main interest is in the field of the medical use of cannabis and cannabinoids, especially for various neuropsychiatric illnesses, such as Chronic Pain Syndrome, Fibromyalgia, Post-Traumatic Stress Disorder (PTSD), OCD, ADHD, Gilles de la Tourette syndrome, Parkinson’s and Alzheimer diseases etc. During last 9 years Dr. Reznik coordinates the activity of Israel National Forum/Association for Medical Cannabis Reseach & Treatment and serves as a professional advisor (and permanent participant and observer) to Israeli Parliament (Knesset) Committee for Drugs and Alcohol Control and to the Parliamentary Public Lobby for Medicinal Cannabis. Dr. Reznik is a renowned international speaker on cannabinoid medicine issues. He is an associate member of the Canadian Consortium for the Investigation of Cannabinoids (CCIC) and a member of the International Cannabinoid Research Society (ICRS). In 2013 he was elected to the Board of Directors, International Association for Cannabinoid Medicines (IACM), and promotes international educational activities within IACM.